Drappa Jorn — SEC Form 4 filings
SEC reporting owner CIK 1789317. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-20 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 2,447 shares, $64,527 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 2,447 shares @ $26.37 ($64,527) in ALUMIS INC., filed 2026-08-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALUMIS INC. (ALMS) | Chief Medical Officer | 6 | — | 1 leg · 2,447 sh · $64,527 | 25 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) | Director | 1 | — | — | 3 |
Form 4 filings — Drappa Jorn
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | ALUMIS INC. (ALMS) | Sale (S): 2,447 @ $26.37 | EDGAR |
| 2026-05-27 | 4 | ALUMIS INC. (ALMS) | Option exercise (M): 11,317 @ $8.84 · Option exercise (M): 15,535 @ $5.06 · Option exercise (M): 11,317 (derivative) @ $0 · Option exercise (M): 15,535 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 221,450 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 25,450 @ $0 · Grant/award (A): 101,850 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 5,347 (derivative) @ $0 · Disposition to issuer (D): 5,347 (derivative) @ $0 · Grant/award (A): 5,347 (derivative) @ $0 · Disposition to issuer (D): 85,561 (derivative) @ $0 · Grant/award (A): 85,561 (derivative) @ $0 · Disposition to issuer (D): 171,122 (derivative) @ $0 · +11 more | EDGAR |
| 2024-05-20 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 17,500 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1789317 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →